ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 127 filers reported holding ANIKA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $401,263 | +22.4% | 17,708 | +0.6% | 0.32% | +6.4% |
Q3 2023 | $327,832 | +29.0% | 17,597 | +79.9% | 0.30% | +32.4% |
Q2 2023 | $254,188 | -9.5% | 9,784 | 0.0% | 0.22% | -12.8% |
Q1 2023 | $280,996 | -2.9% | 9,784 | +0.1% | 0.26% | +4.5% |
Q4 2022 | $289,429 | +4.1% | 9,778 | -21.6% | 0.25% | -11.8% |
Q2 2022 | $278,000 | -10.6% | 12,466 | +0.8% | 0.28% | -45.4% |
Q1 2022 | $311,000 | -4.6% | 12,370 | +36.0% | 0.51% | +76.9% |
Q4 2021 | $326,000 | – | 9,096 | – | 0.29% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 490,331 | $21,928,000 | 10.27% |
CAPITAL MANAGEMENT CORP /VA | 211,660 | $9,465,000 | 3.66% |
AMI ASSET MANAGEMENT CORP | 336,791 | $15,061,000 | 1.03% |
Baltimore-Washington Financial Advisors, Inc. | 68,785 | $3,076,000 | 0.93% |
Portolan Capital Management | 130,939 | $5,856,000 | 0.78% |
Kalos Management, Inc. | 19,254 | $861,000 | 0.72% |
DIKER MANAGEMENT LLC | 32,965 | $1,474,000 | 0.56% |
THOMPSON SIEGEL & WALMSLEY LLC | 1,526,244 | $68,253,000 | 0.56% |
NEW AMSTERDAM PARTNERS LLC/NY | 108,260 | $4,841,000 | 0.51% |
Boston Trust Walden Corp | 493,780 | $22,082,000 | 0.38% |